Northland Capmk Has Pessimistic Outlook of DocGo Q3 Earnings

Key Points

• Northland Capmk has lowered its Q3 2025 earnings per share estimate for DocGo to ($0.09), down from ($0.06), indicating a pessimistic outlook for the company.
• DocGo's previous quarterly earnings report showed a loss of ($0.11) per share, which missed the consensus estimate by ($0.05), alongside a negative net margin of 4.20%.
• Analyst ratings for DocGo are mixed, with a current consensus of “Moderate Buy”, and price targets ranging from $1.45 to $3.00 following adjustments from various firms.

DocGo Inc. (NASDAQ:DCGO - Free Report) - Stock analysts at Northland Capmk decreased their Q3 2025 earnings per share estimates for DocGo in a report released on Monday, August 11th. Northland Capmk analyst M. Latimore now forecasts that the company will post earnings per share of ($0.09) for the quarter, down from their previous forecast of ($0.06). The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q4 2025 earnings at ($0.09) EPS, FY2025 earnings at ($0.36) EPS and Q1 2026 earnings at ($0.02) EPS.

Several other equities research analysts also recently weighed in on DCGO. Canaccord Genuity Group reissued a "hold" rating and set a $1.45 price objective (down previously from $5.00) on shares of DocGo in a report on Monday, May 12th. BTIG Research downgraded DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, Needham & Company LLC cut their price objective on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $3.56.

DocGo Stock Up 8.5%

NASDAQ DCGO opened at $1.66 on Wednesday. DocGo has a twelve month low of $1.23 and a twelve month high of $5.68. The company has a market cap of $169.29 million, a price-to-earnings ratio of -8.74 and a beta of 0.96. The business's fifty day moving average is $1.51 and its 200 day moving average is $2.45.

DocGo (NASDAQ:DCGO - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. The firm had revenue of $80.42 million for the quarter, compared to analyst estimates of $77.58 million.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in DCGO. Vanguard Group Inc. raised its position in shares of DocGo by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 5,014,375 shares of the company's stock worth $21,261,000 after acquiring an additional 14,454 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of DocGo by 199.3% in the 4th quarter. JPMorgan Chase & Co. now owns 328,796 shares of the company's stock worth $1,394,000 after acquiring an additional 218,941 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of DocGo by 31.0% in the 4th quarter. Wells Fargo & Company MN now owns 57,463 shares of the company's stock worth $244,000 after acquiring an additional 13,584 shares in the last quarter. Russell Investments Group Ltd. raised its position in shares of DocGo by 8.0% in the 4th quarter. Russell Investments Group Ltd. now owns 144,116 shares of the company's stock worth $611,000 after acquiring an additional 10,706 shares in the last quarter. Finally, Invesco Ltd. raised its position in shares of DocGo by 1.3% in the 4th quarter. Invesco Ltd. now owns 177,953 shares of the company's stock worth $755,000 after acquiring an additional 2,312 shares in the last quarter. 56.44% of the stock is owned by institutional investors.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.